<DOC>
	<DOCNO>NCT01175811</DOCNO>
	<brief_summary>The purpose study compare effect overall glycaemic control two insulin intensification therapy .</brief_summary>
	<brief_title>A Study Comparing Insulin Intensification Therapies Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Present type 2 diabetes mellitus Have receive twicedaily premixed insulin therapy without metformin and/or alphaglucosidase inhibitor , least six month prior study entry Have Haemoglobin A1c ( HbA1c ) &gt; 7.0 % &lt; 12.0 % Within last 3 month prior entry study , take nonpermitted glucoselowering agent , take nonpermitted oral antihyperglycaemic medication Are pregnant intend become pregnant course study , sexually active woman childbearing potential actively practice birth control method determine investigator medically acceptable . Are woman breastfeed . Have irregular sleep/wake cycle ( example , participant sleep day work night ) . Do regularly consume three meal per day . Have body mass index &gt; 35 kilogram per square meter ( kg/m^2 ) . Have one episode severe hypoglycaemia within 24 week prior entry study . Have cardiac disease functional status Class III IV Have history renal liver disease Have use less equal 20 Units per day ( U/day ) insulin past 90 day 14 day ( accumulate ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Glargine</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Insulin LISPRO</keyword>
	<keyword>Insulin</keyword>
</DOC>